Basic Information
BioMarker Strategies is a tissue-based cancer diagnostics company developing the SnapPath™ live tumor cell testing platform* to improve cancer treatment.
BioMarkerStrategies
Jerusalem,JerusalemDistrict,Israel
15~50 people
January 01, 2006
info@biomarkerstrategies.com

